1 / 20

Metabolic Evaluation of Stone Diseases

Metabolic Evaluation of Stone Diseases

Dr_Sabbagh
Télécharger la présentation

Metabolic Evaluation of Stone Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metabolic Evaluation of Stone Disease Department of Urology Pediatric Unit

  2. Renal stone disease continues to be considerable medical problem, often causing significant patient morbidity.

  3. Main Stone Classification Non-Calcium Stones Calcium Stones

  4. Calcium Stones Calcium Oxalate Dihydrate Calcium- Phosphate Stones Calcium Oxalate Monohydrate

  5. Main Stone Classification Non-Calcium Stones Calcium Stones

  6. Non-Calcium Stones Uric Acid Stones Infecion Stones Cystine Stones Urate Containing Stones Drug Induced Stones Xanthine Stones

  7. Table 1 Types of Urolithiasis Based on Stone Composition (DoritE. Zilberman, Michael N. Ferrandino, and Glenn M. Preminger)

  8. Stones with calcium components develop as a result of the greatest variety of metabolic disorders and often patients present with a combination of stone forming risk factors. Calcium Stones Table 2 Stone Composition & Possible Clinical Associations

  9. Patients with pure uric acid urolithiasisgenerally have a low urinary pH (<5.5) and are therefore defined as having gouty diathesis. Uric Acid Stones Infection Stones • High urinary pH (>7.5) is associated with infection. Urea splitting organisms leads to an increase in the ammonia concentration, which promotes infection stone formation, which compose the majority of stag-horn calculi.

  10. Cystineurolithiasis is the result of an autosomal recessive trait, which disrupts the transepithelial transport of cystine, ornithine, lysine, and arginine. The concentration of cystine rises to levels above the saturation point, leading to precepitation of cystine crystals. • Even though cystine stone formers all have definitive genetic disorders, they have been found to have a number of other metabolic risk factors, which can contribute to their stone formation Cystine-Based Stones

  11. Metabolic Evaluation of Stone Disease • Why? • The main goal of metabolic evaluation is to prevent recurrent stone formation in high-risk stone producers, as well as to prevent further growth of any existing stones.

  12. Metabolic Evaluation of Stone Disease Who? 1. Patient with stone who wishes to undergo metabolic evaluation 2. Single stone with risk factors: a. Family history b. Intestinal disease c. Chronic diarrhea d. UTI e. Gouty f. Osteoporosis g. Skeletal fractures 3. Recurrent stone formers 4. Children 5. Controversial: uric acid/struvite/cystine stones

  13. Metabolic Evaluation of Stone Disease • When? • Many authors suggest that one should wait at least 1 month after stone passage or stone removal, allowing the patient to return to their normal routine, otherwise the metabolic evluation may yield unhelpful information.

  14. Metabolic Evaluation of Stone Disease • How? • History & Examination • Stone Analysis • Serum Chemistry • Urine Culture • Urinalysis • 24 hour urine collection • Radiological Imaging

  15. Metabolic Work-up of Stone Disease • The basic metabolic evaluation begins with a thorough history and physical exam, (similar previous conditions or family history) • Stone Analysis: For patients with less common stone compositions – cystine, pure struvite, and pure uric acid –treatment regimens could begin immediately. • Patients with calcium phosphate stones are known to be at increased risk from renal tubular acidosis and primary hyperparathyroidism, while patients with calcium oxalate stone formation have a mixture of metabolic diagnoses.

  16. Metabolic Work-up of Stone Disease • Serum chemistry consists of basic metabolic panel (e.g., sodium, potassium, chloride, carbon dioxide, blood urea nitrogen, creatinine) as well as calcium and uric acid. • Hypercalcemiamay be indicative of hyperparathyroidism and would warrant further evaluation with a parathyroid hormone assay. The presence of hypokalemia and hyper-chloremia is strongly suggestive of metabolic acidosis

  17. Metabolic Work-up of Stone Disease • Urine Culturespositive for Klebsiella, Proteus, Pseudomonas, or other urea-splitting organisms may indicate the presence of struvite stone • Urine Analysis with PH between 6.8 and 7.2 suggestive of RTA, a pH greater than 7.5 correlated with urinary tract infection whereas a pH less than 5.5 defines the diagnosis of gouty diathesis.

  18. Metabolic Work-up of Stone Disease • 24 hour collection of urine to measure: total volume, pH, calcium, phosphorus, oxalate, citrate, sodium, magnesium, potassium, uric acid, and sulfate. • It is our routine to have the patient collect two 24 h urine samples on two different days (either consecutive or separate) with the patient on their “normal routine” (normal diet, fluid intake, medications, physical exercise, etc) .

  19. Metabolic Work-up of Stone Disease • Many Authors consider radiologic imaging as a part of the basic metabolic evaluation, as there are insights which can be gleaned from the different imaging techniques. • For example, multiple researchers have reported the use of CT to ascertain stone composition based on measurement of Hounsfield units

  20. Thank You Ahmad Al-Sabbagh - December 2011*

More Related